...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix presenting at Vascular Discovery 2019 next week

Bear,

question for you.  

Let's say that during the Phase 3 trials that took place over the last 3 years, Resverlogix discovers something new...like c reactive protein going down significantly during these Phase 3 trials.  Can they now go back to the data collected during Phase 2, run statistical analysis on that exact item (c reactive protein) and then present it as an original research paper, like they are now doing?  Obviously I don't know if cRP went down or not...I am merely using cRP as an example.

 

Thanks

iconoclast

Share
New Message
Please login to post a reply